immunoglobulin A
Showing 26 - 50 of 4,146
PANS Pediatric Acute-Onset Neuropsychiatric Syndrome Trial in Gothenburg (Privigen Injectable Product (Intravenous
Recruiting
- PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
- Privigen Injectable Product (Intravenous Immunoglobulin)
-
Gothenburg, SwedenGillberg Neuropsychiatry Centre
Aug 13, 2022
MRD Detection by NGS in Pediatric B-ALL
Completed
- Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
- MRD
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023
Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin
Not yet recruiting
- Immune Thrombocytopenia
- Pregnancy Related
- intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- intravenous immunoglobulin
- (no location specified)
Dec 1, 2022
Subcutaneous Immunoglobulin in Primary and Secondary
Not yet recruiting
- Primary Immune Deficiency Disorder
- Secondary Immune Deficiency
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 14, 2022
Outcomes Study (FIGARO)
Completed
- Primary Immunodeficiency
- Secondary Immune Deficiency
- HyQvia
-
Paris, France
- +3 more
Mar 18, 2022
Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)
Recruiting
- Immunoglobulin A Nephropathy
- +5 more
-
Leicester, United KingdomLeicester General Hospital, University Hospitals of Leicester NH
May 18, 2022
GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))
Recruiting
- Graft Versus Host Disease
- Cyclophosphamide
- anti-human T-lymphocyte immunoglobulin (ATLG)
-
Ramat Gan, IsraelChaim Sheba Medical Center
May 4, 2022
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Recruiting
- Allergy and Immunology
- collection of blood and urine
-
Toulouse, France
- +1 more
May 17, 2022
Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Not yet recruiting
- Immunoglobulin Light-chain Amyloidosis
- Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- (no location specified)
Mar 18, 2023
Female Reproductive Cancer Trial in Rochester (serum-derived bovine immunoglobulin protein isolate, , laboratory biomarker
Active, not recruiting
- Female Reproductive Cancer
- serum-derived bovine immunoglobulin protein isolate
- +4 more
-
Rochester, MinnesotaMayo Clinic
Feb 3, 2022
Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)
Recruiting
- Advanced Malignant Tumors
- doxorubicin hydrochloride liposome injection
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 28, 2022
Kawasaki Disease Trial in Le Kremlin-Bicêtre (ANAKINRA, Intravenous immunoglobulin)
Not yet recruiting
- Kawasaki Disease
- ANAKINRA
- Intravenous immunoglobulin
-
Le Kremlin-Bicêtre, Val De Marne, FranceCHU de Bicêtre
Jun 17, 2022
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg, Placebo)
Recruiting
- Immunoglobulin A Nephropathy
- Sibeprenlimab 400 mg
- Placebo
-
New York, New YorkFor additional information regarding sites, contact 844-687-8522
Mar 25, 2022
Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))
Completed
- Tetanus
- TNM002 (low dose)
- +4 more
-
Shantou, Guangdong, China
- +3 more
Nov 20, 2022
HFRS (Hemorrhagic Fever With Renal Syndrome) Trial in China (IVIG 20g/d, IVIG 10g/d)
Recruiting
- HFRS (Hemorrhagic Fever With Renal Syndrome)
- IVIG 20g/d
- IVIG 10g/d
-
Guangshui, Hu Bei Province, China
- +8 more
Aug 22, 2023
Rabies Post-exposure Prophylaxis Trial in Kunming (GR1801, Human Rabies Immunoglobulin(HRIG), Rabies Vaccine)
Recruiting
- Rabies Post-exposure Prophylaxis
- GR1801
- +2 more
-
Kunming, Yunnan, ChinaCenter for Disease Control and Prevention (CDC)
May 3, 2023
Bronchiectasis, Immunoglobulin Subclass Deficiency Trial in Edinburgh (Cuvitru 20 % Injectable Solution)
Withdrawn
- Bronchiectasis
- Immunoglobulin Subclass Deficiency
- Cuvitru 20 % Injectable Solution
-
Edinburgh, United KingdomRoyal Infirmary of Edinburgh
Sep 28, 2021
Lymphoma Trial in Seattle (biological, other, procedure)
Not yet recruiting
- Lymphoma
- Immune Globulin Infusion (Human), 10% Solution
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2023
Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)
Not yet recruiting
- Proliferative Glomerulonephritis With Monoclonal IgG Deposits
-
Rochester, MinnesotaMayo Clinic Minnesota
Dec 8, 2022
Intravenous Immunoglobulin Treatment in Chronic Inflammatory
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg s.c. Q4weeks)
Not yet recruiting
- Immunoglobulin A Nephropathy
- Sibeprenlimab 400 mg s.c. Q4weeks
-
New York, New YorkFor additional information regarding sites, contact 844-687-8522
Feb 18, 2022